ATE284414T1 - Menschliche defensin def-x, gen und cdna, deren enthaltende zusammensetzungen und deren diagnostische und therapeutische anwendungen - Google Patents

Menschliche defensin def-x, gen und cdna, deren enthaltende zusammensetzungen und deren diagnostische und therapeutische anwendungen

Info

Publication number
ATE284414T1
ATE284414T1 AT98942796T AT98942796T ATE284414T1 AT E284414 T1 ATE284414 T1 AT E284414T1 AT 98942796 T AT98942796 T AT 98942796T AT 98942796 T AT98942796 T AT 98942796T AT E284414 T1 ATE284414 T1 AT E284414T1
Authority
AT
Austria
Prior art keywords
def
cdna
diagnostic
gene
therapeutic applications
Prior art date
Application number
AT98942796T
Other languages
English (en)
Inventor
Lydie Bougueleret
Ilya Chumakov
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Application granted granted Critical
Publication of ATE284414T1 publication Critical patent/ATE284414T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
AT98942796T 1997-08-29 1998-08-28 Menschliche defensin def-x, gen und cdna, deren enthaltende zusammensetzungen und deren diagnostische und therapeutische anwendungen ATE284414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9710823A FR2767832B1 (fr) 1997-08-29 1997-08-29 Polypeptide defensine humaine def-x, adn genomique et adnc, composition les contenant et applications au diagnostic et au traitement therapeutique
PCT/FR1998/001864 WO1999011663A1 (fr) 1997-08-29 1998-08-28 DEFENSINE HUMAINE DEF-X, GENE ET cDNA, COMPOSITION LES CONTENANT ET APPLICATIONS AU DIAGNOSTIC ET A LA THERAPIE

Publications (1)

Publication Number Publication Date
ATE284414T1 true ATE284414T1 (de) 2004-12-15

Family

ID=9510617

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942796T ATE284414T1 (de) 1997-08-29 1998-08-28 Menschliche defensin def-x, gen und cdna, deren enthaltende zusammensetzungen und deren diagnostische und therapeutische anwendungen

Country Status (11)

Country Link
US (3) US6329340B1 (de)
EP (1) EP1009767B1 (de)
JP (1) JP2001514264A (de)
AT (1) ATE284414T1 (de)
AU (1) AU759482B2 (de)
CA (1) CA2299560C (de)
DE (1) DE69828063T2 (de)
ES (1) ES2230714T3 (de)
FR (1) FR2767832B1 (de)
PT (1) PT1009767E (de)
WO (1) WO1999011663A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
US7511015B2 (en) * 2002-02-19 2009-03-31 The United States Of America As Represented By The Department Of Health And Human Services Modified defensins and their use
US7119070B2 (en) 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
US20040096820A1 (en) * 2002-05-31 2004-05-20 Ciphergen Biosystems, Inc. Comparative proteomics of progressor and nonprogressor populations
US20040091498A1 (en) * 2002-05-31 2004-05-13 Aaron Diamond Aids Research Center Defensins: use as antiviral agents
EP1540341A4 (de) * 2002-07-01 2007-01-10 Univ Rochester Medical Ct Verfahren zur bestimmung der wahrscheinlichkeit eines auftretens vorzeitiger wehen in schwangeren frauen
GB0223655D0 (en) 2002-10-10 2002-11-20 Mabtech Ab Method of diagnosis
US20060115480A1 (en) * 2002-12-19 2006-06-01 Yitzchak Hillman Disease treatment via antimicrobial peptide inhibitors
CA2526878A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US8202835B2 (en) 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US9044438B2 (en) 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
HRP20211983T1 (hr) 2014-06-18 2022-08-19 Medicell Technologies, Llc Pripravci za i postupci stimuliranja matičnih stanica
RU2597789C2 (ru) * 2014-11-10 2016-09-20 Илья Владимирович Духовлинов Анальгетическое средство на основе плазмидной днк, кодирующей hnp-1, либо hnp-2, либо hnp-3 (варианты)
WO2024036134A2 (en) * 2022-08-08 2024-02-15 Sri International Defensin proteins for infection assessment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
JPH07507213A (ja) * 1992-05-22 1995-08-10 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 消化器デフェンシン,そのcDNA配列及び製造方法並びにその使用
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
US5550109A (en) * 1994-05-24 1996-08-27 Magainin Pharmaceuticals Inc. Inducible defensin peptide from mammalian epithelia

Also Published As

Publication number Publication date
JP2001514264A (ja) 2001-09-11
US6329340B1 (en) 2001-12-11
US6960441B2 (en) 2005-11-01
DE69828063T2 (de) 2005-12-01
EP1009767B1 (de) 2004-12-08
ES2230714T3 (es) 2005-05-01
US20020115151A1 (en) 2002-08-22
AU9079898A (en) 1999-03-22
AU759482B2 (en) 2003-04-17
FR2767832A1 (fr) 1999-03-05
FR2767832B1 (fr) 2001-08-10
CA2299560C (fr) 2012-03-20
DE69828063D1 (de) 2005-01-13
US7105651B2 (en) 2006-09-12
PT1009767E (pt) 2005-02-28
CA2299560A1 (fr) 1999-03-11
WO1999011663A1 (fr) 1999-03-11
US20020182703A1 (en) 2002-12-05
EP1009767A1 (de) 2000-06-21

Similar Documents

Publication Publication Date Title
DE69828063D1 (de) Menschliche defensin def-x, gen und cdna, deren enthaltende zusammensetzungen und deren diagnostische und therapeutische anwendungen
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
BRPI0412993A (pt) inibidores da atividade da akt
PL374326A1 (pl) Mikroorganizmy i komórki do diagnozy i terapii przeciwrakowej
PT1131065E (pt) Fumaratos dialquilicos para o tratamento de doencas autoimunes
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
BR9405507A (pt) Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
IT1270123B (it) Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
DE69905170T2 (de) Thiazolopyrimidinderivate
DE69534165D1 (de) Adenovirus mit glutathion peroxydate gene
NZ515964A (en) A method for the prophylaxis and/or treatment of medical disorders
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
BR0010563A (pt) Composições isoladas de células da pele e métodos para seu uso
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
BR0206852A (pt) Conjugados de polìmero de neublastina e métodos para uso dos mesmos
CA2265444A1 (en) Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
BRPI0408468A (pt) métodos para preparação e uso de 1(alfa),24(s)-diidroxivitamina d2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1009767

Country of ref document: EP